Human α1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by α1β1 integrin

Original citation: J Clin Invest. 2005;115(10):2801–2810. https://doi.org/10.1172/JCI24813

Citation for this retraction: J Clin Invest. 2020;130(1):552. https://doi.org/10.1172/JCI135305

The Office of Research Integrity recently notified the JCI of falsified data reported in this article. Therefore, the JCI is retracting the article.

Version 1. 01/02/2020

Print issue publication